# RCUS (Arcus Biosciences, Inc.) - SEC EDGAR Financial Statements

> Arcus Biosciences, Inc. reported $100.0M in revenue and a net loss of $453.0M for the trailing twelve months ended September 30, 2026 (down 65.4% year over year), with a -475.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/RCUS
- Markdown: https://convexityos.com/fundamentals/RCUS.md
- SEC CIK: 0001724521
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:21 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001724521&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $100.0M | -65.4% YoY |
| Operating Income | TTM | -$475.0M | -475.0% margin |
| Net Income | TTM | -$453.0M | -453.0% net margin |
| Diluted EPS | TTM | -$3.56 | Split-adjusted |
| Free Cash Flow | TTM | -$466.0M | -466.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $630.0M | Total debt: $116.0M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $247.0M | $258.0M | $117.0M | $112.0M | $383.0M | $78.00M | $15.00M | $8.35M | $1.41M | -- |
| Research & Development | $523.0M | $448.0M | $340.0M | $288.0M | $257.0M | $159.0M | $78.48M | $49.65M | $47.22M | $14.25M |
| Total Operating Expenses | $633.0M | $588.0M | $457.0M | $392.0M | $329.0M | $202.0M | $103.7M | $63.21M | $54.85M | $18.18M |
| **Operating Income** | -$386.0M | -$330.0M | -$340.0M | -$280.0M | $54.00M | -$124.0M | -$88.71M | -$54.86M | -$53.44M | -$18.18M |
| **EBITDA** | -$376.0M | -$320.0M | -$332.0M | -$274.0M | $58.00M | -$121.0M | -$85.13M | -$51.20M | -$50.83M | -$16.87M |
| Interest Expense | $8.00M | $4.00M | $2.00M | $2.00M | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$353.0M | -$282.0M | -$301.0M | -$266.0M | $55.00M | -$123.0M | -$84.71M | -- | -- | -- |
| Income Tax Expense | $0 | $1.00M | $6.00M | $1.00M | $2.00M | -- | -- | -- | -- | -- |
| **Net Income** | -$353.0M | -$283.0M | -$307.0M | -$267.0M | $53.00M | -$123.0M | -$84.71M | -$49.59M | -$53.08M | -$17.97M |
| Basic EPS | -$3.29 | -$3.14 | -$4.15 | -$3.71 | $0.76 | -$2.24 | -$1.93 | -$1.43 | -$29.03 | -$20.80 |
| **Diluted EPS** | -$3.29 | -$3.14 | -$4.15 | -$3.71 | $0.71 | -$2.24 | -$1.93 | -$1.43 | -$29.03 | -$20.80 |
| Basic Shares Outstanding | 107.4M | 90.1M | 74.0M | 72.0M | 69.3M | 54.8M | 43.8M | 36.4M | 3.9M | 3.4M |
| Diluted Shares Outstanding | 107.4M | 90.1M | 74.0M | 72.0M | 74.0M | 54.8M | 43.8M | 34.6M | 1.8M | 864.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $9.00M | $41.00M | $17.00M | $33.00M | $26.00M | $160.0M | $28.00M | $26.00M |
| Research & Development | $117.0M | $113.0M | $122.0M | $121.0M | $141.0M | $139.0M | $122.0M | $101.0M |
| Total Operating Expenses | $140.0M | $137.0M | $151.0M | $147.0M | $168.0M | $168.0M | $150.0M | $129.0M |
| **Operating Income** | -$131.0M | -$96.00M | -$134.0M | -$114.0M | -$142.0M | -$8.00M | -$122.0M | -$103.0M |
| **EBITDA** | -$129.0M | -$93.00M | -$132.0M | -$111.0M | -$140.0M | -$6.00M | -$119.0M | -$100.0M |
| Interest Expense | $3.00M | $3.00M | $3.00M | $2.00M | $3.00M | $2.00M | $1.00M | $2.00M |
| Income Before Tax | -$128.0M | -$91.00M | -$128.0M | -$106.0M | -$135.0M | $0 | -$112.0M | -$93.00M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.00M |
| **Net Income** | -$128.0M | -$91.00M | -$128.0M | -$106.0M | -$135.0M | $0 | -$112.0M | -$94.00M |
| Basic EPS | -$1.00 | -$0.72 | -$1.02 | -- | -$1.27 | $0.00 | -$1.14 | -- |
| **Diluted EPS** | -$1.00 | -$0.72 | -$1.02 | -- | -$1.27 | $0.00 | -$1.14 | -- |
| Basic Shares Outstanding | 127.4M | 126.1M | 125.4M | -- | 106.5M | 106.1M | 98.4M | -- |
| Diluted Shares Outstanding | 127.4M | 126.1M | 125.4M | -- | 106.5M | 106.5M | 98.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $222.0M | $150.0M | $127.0M | $206.0M | $148.0M | $173.4M | $57.94M | $71.06M | $98.43M |
| Short-Term Investments | $759.0M | $828.0M | $632.0M | $803.0M | $351.0M | $555.2M | -- | -- | -- |
| **Cash & Short-Term Investments** | $981.0M | $978.0M | $759.0M | $1.01B | $499.0M | $728.6M | $57.94M | $71.06M | $98.43M |
| **Total Current Assets** | $1.01B | $1.02B | $831.0M | $1.07B | $1.26B | $735.8M | $192.7M | $258.9M | $176.9M |
| Property, Plant & Equipment, Net | $40.00M | $47.00M | $51.00M | $35.00M | $32.00M | $10.81M | $9.33M | $11.11M | $11.23M |
| Long-Term Investments | $29.00M | $14.00M | $107.0M | $129.0M | $182.0M | $6.44M | -- | -- | -- |
| Other Non-Current Assets | $63.00M | $73.00M | $106.0M | $114.0M | $116.0M | $6.25M | $872K | $284K | $1.50M |
| **Total Non-Current Assets** | $132.0M | $134.0M | $264.0M | $278.0M | $330.0M | $36.48M | $10.40M | $15.98M | $13.62M |
| **Total Assets** | $1.14B | $1.15B | $1.09B | $1.34B | $1.59B | $772.3M | $203.1M | $274.9M | $190.5M |
| Accounts Payable | $42.00M | $18.00M | $17.00M | $20.00M | $10.00M | $15.68M | $4.70M | $3.10M | $3.82M |
| Deferred Revenue (Current) | $35.00M | $85.00M | $91.00M | $97.00M | $102.0M | $74.57M | $7.00M | $6.25M | $5.00M |
| Other Current Liabilities | $154.0M | $123.0M | $76.00M | $76.00M | $54.00M | $3.57M | $1.48M | $1.56M | $769K |
| **Total Current Liabilities** | $231.0M | $226.0M | $184.0M | $193.0M | $166.0M | $121.7M | $22.71M | $16.93M | $12.73M |
| Long-Term Debt | $99.00M | $48.00M | $0 | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $43.00M | $234.0M | $307.0M | $355.0M | $462.0M | $132.5M | $12.02M | $16.98M | $18.59M |
| Other Non-Current Liabilities | $135.0M | $157.0M | $142.0M | $140.0M | $122.0M | $543K | $806K | $1.79M | $565K |
| **Total Non-Current Liabilities** | $277.0M | $439.0M | $449.0M | $495.0M | $584.4M | $148.3M | $16.56M | $23.05M | $23.89M |
| **Total Liabilities** | $508.0M | $665.0M | $633.0M | $688.0M | $750.4M | $270.0M | $39.27M | $39.98M | $36.62M |
| **Total Debt (incl. Leases)** | $198.0M | $159.0M | $121.0M | $126.0M | $113.6M | $18.11M | -- | -- | -- |
| Common Stock | $2.12B | $1.62B | $1.31B | $1.21B | $1.12B | $6.0K | $4.0K | $4.0K | -- |
| Retained Earnings | -$1.49B | -$1.13B | -$849.0M | -$542.0M | -$275.0M | -$328.2M | -$205.3M | -$122.8M | -$73.23M |
| Accumulated Other Comp. Income | $0 | -- | $0 | -$7.00M | -$1.00M | $44K | $64K | -$107K | -$42K |
| **Total Stockholders' Equity** | $631.0M | $485.0M | $462.0M | $657.0M | $842.0M | $502.0M | $164.0M | $234.9M | -$72.33M |
| Total Equity | $631.0M | $485.0M | $462.0M | $657.0M | $842.0M | $502.0M | $164.0M | $234.9M | -$72.33M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $151.0M | $150.0M | $201.0M | $222.0M | $238.0M | $248.0M | $192.0M | $150.0M |
| Short-Term Investments | $479.0M | $552.0M | $621.0M | $759.0M | $593.0M | $663.0M | $805.0M | $828.0M |
| **Cash & Short-Term Investments** | $630.0M | $702.0M | $822.0M | $981.0M | $831.0M | $911.0M | $997.0M | $978.0M |
| **Total Current Assets** | $664.0M | $756.0M | $844.0M | $1.01B | $857.0M | $946.0M | $1.03B | $1.02B |
| Property, Plant & Equipment, Net | $33.00M | $36.00M | $38.00M | $40.00M | $42.00M | $44.00M | $46.00M | $47.00M |
| Long-Term Investments | $64.00M | $73.00M | $54.00M | $29.00M | $10.00M | $16.00M | $8.00M | $14.00M |
| Other Non-Current Assets | $57.00M | $59.00M | $61.00M | $63.00M | $65.00M | $69.00M | $71.00M | $73.00M |
| **Total Non-Current Assets** | $154.0M | $168.0M | $153.0M | $132.0M | $117.0M | $129.0M | $125.0M | $134.0M |
| **Total Assets** | $818.0M | $924.0M | $997.0M | $1.14B | $974.0M | $1.07B | $1.16B | $1.15B |
| Accounts Payable | $44.00M | $34.00M | $39.00M | $42.00M | $42.00M | $29.00M | $22.00M | $18.00M |
| Deferred Revenue (Current) | $14.00M | $19.00M | $34.00M | $35.00M | $52.00M | $71.00M | $72.00M | $85.00M |
| Other Current Liabilities | $141.0M | $145.0M | $136.0M | $154.0M | $141.0M | $110.0M | $98.00M | $123.0M |
| **Total Current Liabilities** | $199.0M | $198.0M | $209.0M | $231.0M | $235.0M | $210.0M | $192.0M | $226.0M |
| Long-Term Debt | $102.0M | $101.0M | $100.0M | $99.00M | $98.00M | $97.00M | $48.00M | $48.00M |
| Deferred Revenue (Non-Current) | $34.00M | $37.00M | $45.00M | $43.00M | $53.00M | $60.00M | $219.0M | $234.0M |
| Other Non-Current Liabilities | $125.0M | $124.0M | $119.0M | $135.0M | $152.0M | $159.0M | $166.0M | $157.0M |
| **Total Non-Current Liabilities** | $261.0M | $262.0M | $264.0M | $277.0M | $303.0M | $316.0M | $433.0M | $439.0M |
| **Total Liabilities** | $460.0M | $460.0M | $473.0M | $508.0M | $538.0M | $526.0M | $625.0M | $665.0M |
| **Total Debt (incl. Leases)** | $116.0M | $114.0M | $113.0M | $198.0M | $111.0M | $109.0M | $60.00M | $159.0M |
| Common Stock | $2.19B | $2.17B | $2.14B | $2.12B | $1.81B | $1.79B | $1.77B | $1.62B |
| Retained Earnings | -$1.83B | -$1.70B | -$1.61B | -$1.49B | -$1.38B | -$1.24B | -$1.24B | -$1.13B |
| Accumulated Other Comp. Income | -$2.00M | -$1.00M | -$1.00M | $0 | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $358.0M | $464.0M | $524.0M | $631.0M | $436.0M | $549.0M | $531.0M | $485.0M |
| Total Equity | $358.0M | $464.0M | $524.0M | $631.0M | $436.0M | $549.0M | $531.0M | $485.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$353.0M | -$283.0M | -$307.0M | -$267.0M | $53.00M | -$123.0M | -$84.71M | -$49.59M | -$53.08M | -$17.97M |
| Depreciation & Amortization | $10.00M | $10.00M | $8.00M | $6.00M | $4.00M | $3.00M | $3.58M | $3.66M | $2.61M | $1.31M |
| Stock-Based Compensation | $60.00M | $76.00M | $73.00M | $65.00M | $55.00M | $22.00M | $8.98M | $3.87M | $495K | $90K |
| Change in Payables | $24.00M | $3.00M | -$1.00M | $8.00M | -$5.00M | $9.00M | $1.73M | -$69K | -$267K | $3.57M |
| **Operating Cash Flow** | -$482.0M | -$170.0M | -$306.0M | $438.0M | -$256.0M | $111.0M | -$73.46M | -$43.00M | -$25.06M | -$12.94M |
| Capital Expenditure | -$2.00M | -$6.00M | -$24.00M | -$6.00M | -$26.00M | -$3.00M | -$1.93M | -$3.74M | -$5.51M | -$4.10M |
| **Free Cash Flow** | -$484.0M | -$176.0M | -$330.0M | $432.0M | -$282.0M | $108.0M | -$75.39M | -$46.74M | -$30.57M | -$17.04M |
| Purchases of Investments | -$1.08B | -$1.04B | -$788.0M | -$1.24B | -$718.9M | -$739.7M | -$247.8M | -$261.6M | -$96.83M | -$33.76M |
| Sales & Maturities of Investments | -- | -- | -- | -- | $690.1M | $307.3M | $308.9M | $151.9M | $53.27M | $0 |
| **Investing Cash Flow** | $66.00M | -$84.00M | $194.0M | -$413.0M | -$4.00M | -$434.0M | $59.21M | -$113.4M | -$49.07M | -$38.86M |
| Common Stock Issued | $429.0M | $228.0M | $25.00M | $0 | $220.0M | $434.0M | $1.22M | $4.10M | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -$94K | $0 | -- | -- |
| **Financing Cash Flow** | $488.0M | $277.0M | $33.00M | $33.00M | $237.0M | $439.0M | $1.12M | $129.1M | $107.4M | $70.10M |
| **Net Change in Cash** | $72.00M | $23.00M | -$79.00M | $58.00M | -$23.00M | $116.0M | -$13.13M | -$27.36M | $33.27M | $18.30M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$128.0M | -$91.00M | -$128.0M | -$106.0M | -$135.0M | $0 | -$112.0M | -$94.00M |
| Depreciation & Amortization | $2.00M | $3.00M | $2.00M | $3.00M | $2.00M | $2.00M | $3.00M | $3.00M |
| Stock-Based Compensation | $16.00M | $15.00M | $19.00M | $15.00M | $14.00M | $15.00M | $16.00M | $17.00M |
| Change in Payables | $10.00M | -$5.00M | -$3.00M | $0 | $13.00M | $8.00M | $3.00M | $5.00M |
| **Operating Cash Flow** | -$88.00M | -$119.0M | -$138.0M | -$120.0M | -$97.00M | -$133.0M | -$132.0M | -$100.0M |
| Capital Expenditure | $0 | $0 | $0 | -$1.00M | $0 | $0 | -$1.00M | -$1.00M |
| **Free Cash Flow** | -$88.00M | -$119.0M | -$138.0M | -$121.0M | -$97.00M | -$133.0M | -$133.0M | -$101.0M |
| Purchases of Investments | -$131.0M | -$182.0M | -$150.0M | -$397.0M | -$165.0M | -$161.0M | -$353.0M | -$172.0M |
| **Investing Cash Flow** | $82.00M | $52.00M | $114.0M | -$182.0M | $79.00M | $137.0M | $32.00M | $51.00M |
| Common Stock Issued | $0 | $0 | $0 | $279.0M | $8.00M | $0 | $142.0M | $0 |
| **Financing Cash Flow** | $7.00M | $16.00M | $3.00M | $286.0M | $8.00M | $52.00M | $142.0M | -$2.00M |
| **Net Change in Cash** | $1.00M | -$51.00M | -$21.00M | -$16.00M | -$10.00M | $56.00M | $42.00M | -$51.00M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -156.3% | -127.9% | -290.6% | -250.0% | 14.1% | -159.0% | -591.4% | -656.8% | -3782.1% | -- |
| **Net Profit Margin** | -142.9% | -109.7% | -262.4% | -238.4% | 13.8% | -157.7% | -564.7% | -593.7% | -3756.7% | -- |
| Return on Equity (ROE) | -55.9% | -58.4% | -66.5% | -40.6% | 6.3% | -24.5% | -51.7% | -21.1% | -- | -- |
| Return on Assets (ROA) | -31.0% | -24.6% | -28.0% | -19.9% | 3.3% | -15.9% | -41.7% | -18.0% | -27.9% | -- |
| Current Ratio | 4.36x | 4.50x | 4.52x | 5.53x | 7.60x | 6.05x | 8.49x | 15.29x | 13.90x | -- |
| Quick Ratio | 4.25x | 4.33x | 4.12x | 5.23x | 3.01x | 5.99x | 2.55x | 4.20x | 7.73x | -- |
| Debt to Equity | 0.31x | 0.33x | 0.26x | 0.19x | 0.13x | 0.04x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -4.3% | +120.5% | +4.5% | -70.8% | +391.0% | +420.0% | +79.6% | +491.2% | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -618.5% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -603.8% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -588.2% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -169.9% | -- | -330.6% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -176.4% | -- | -361.1% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +61.6% | +736.6% | +588.2% | +327.8% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -475.0% | -415.4% | -168.6% | -156.3% | -156.2% | -129.0% | -309.2% | -127.9% |
| **Net Profit Margin** | -453.0% | -393.2% | -156.4% | -142.9% | -142.1% | -113.7% | -277.3% | -109.7% |
| Return on Equity (ROE) | -126.5% | -99.1% | -70.4% | -55.9% | -78.2% | -54.3% | -73.6% | -58.4% |
| Return on Assets (ROA) | -55.4% | -49.8% | -37.0% | -31.0% | -35.0% | -27.7% | -33.8% | -24.6% |
| Current Ratio | 3.34x | 3.82x | 4.04x | 4.36x | 3.65x | 4.50x | 5.37x | 4.50x |
| Quick Ratio | 3.17x | 3.55x | 3.93x | 4.25x | 3.54x | 4.34x | 5.19x | 4.33x |
| Debt to Equity | 0.32x | 0.25x | 0.22x | 0.31x | 0.25x | 0.20x | 0.11x | 0.33x |
| **Revenue Growth (YoY)** | -65.4% | -74.4% | -39.3% | +26.9% | -45.8% | +310.3% | -80.7% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -473.1% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -488.0% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
